0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
48 Ansichten2 Seiten
Bt brinjal is a transgenic brinjal created by inserting a crystal gene (Cry1Ac) from the soil bacterium Bacillus th uringiensis into the brinjal's genome. The gene, along with oth er genetic elements like promoters, terminators and an antibiotic resistance mar ker gene has been developed to give resistance against lepidop teron insects. It was approved for commercialization in India in 2009, but after a
Bt brinjal is a transgenic brinjal created by inserting a crystal gene (Cry1Ac) from the soil bacterium Bacillus th uringiensis into the brinjal's genome. The gene, along with oth er genetic elements like promoters, terminators and an antibiotic resistance mar ker gene has been developed to give resistance against lepidop teron insects. It was approved for commercialization in India in 2009, but after a
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als TXT, PDF, TXT herunterladen oder online auf Scribd lesen
Bt brinjal is a transgenic brinjal created by inserting a crystal gene (Cry1Ac) from the soil bacterium Bacillus th uringiensis into the brinjal's genome. The gene, along with oth er genetic elements like promoters, terminators and an antibiotic resistance mar ker gene has been developed to give resistance against lepidop teron insects. It was approved for commercialization in India in 2009, but after a
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als TXT, PDF, TXT herunterladen oder online auf Scribd lesen
The Bt brinjal is a transgenic brinjal (also known as an eggplant or aubergine)
created by inserting a crystal gene (Cry1Ac) from the soil bacterium Bacillus th uringiensis into the brinjal's genome. The insertion of the gene, along with oth er genetic elements like promoters, terminators and an antibiotic resistance mar ker gene into the brinjal plant is accomplished using Agrobacterium-mediated rec ombination. The Bt brinjal has been developed to give resistance against lepidop teron insects, in particular the Brinjal Fruit and Shoot Borer (Leucinodes orbon alis)(FSB). Monsanto, a multinational company based in the USA, has developed th e Bt brinjal in partnership with India's Maharashtra Hybrid Seeds Company (Mahyc o). It was approved for commercialization in India in 2009, but after a public o utcry the Indian government applied a moratorium on its release. Development Mahyco developed the DNA construct that contains a modified insecticidal cry1Ac gene obtained from Monsanto and two supporting genes (nptII and aad). The cry1Ac gene is under the transcriptional control of an enhanced Cauliflower mosaic vir us 35S (CaMV35S) promoter, which ensures the gene is expressed in all the brinja ls tissue throughout its complete life cycle. NptII and aad are selectable marke r genes, nptII is used to identify transgenic plants from non-transgenic and aad is used to identify the transformed bacteria used during the development of the construct. Aad contains a bacterial promoter and is not expressed in the Bt Bri njal. The completed construct was inserted into young cotyledons from the brinja l plants using agrobacterium-mediated techniques. Agrobacterium naturally insert s DNA into plants from its Ti plasmid and scientists use this to insert their ge nes of interest into various plants. The transformed plants were regenerated and analyzed for the presence of the gene through Southern blotting. The plants pro geny were also analyzed to identify lines segregating in a Mendelian fashion Attempted commercialization in India An expert committee (EC-I) was set up in 2006 to examine the biosafety data pres ented by Mahyco. They concluded that while the current data demonstrated that Bt brinjal was safe and equivalent to its non Bt counterpart, more studies were re quired to re-affirm the findings and further trials were needed to ascertain the benefits from Bt brinjal with respect to existing methods for pest management a nd pesticide reduction. They recommended that large scale trials be allowed to g o ahead. In 2009 a second expert committee (EC-II) examined the data from these trials. They concluded that adequate safety tests had been performed, stating th at "the benefits of Bt brinjal event EE-I developed by M/s Mahyco far outweigh t he perceived and projected risks", and advised the Genetic Engineering Appraisal Committee (GEAC) to recommend commercialization of the Bt brinjal. The GEAC cleared Bt brinjal for commercialization on 14 October 2009. Following concerns raised by some scientists, farmers and anti-GM activists the government of India officially announced on 9 February 2010 that it needed more time befor e releasing Bt brinjal, with Indian Environment Minister Jairam Ramesh saying th at there is no overriding urgency to introduce Bt brinjal in India. On 17 Februa ry 2010, Jairam Ramesh reiterated that the Centre had only imposed a moratorium on the release of transgenic brinjal hybrid, and not a permanent ban, saying tha t â until we arrive at a political, scientific and societal consensus, this moratoriu m will remainâ . Companies with any seeds of Bt brinjal will have to register the det ails with the government and the National Bureau of Plant Genetic Resources (NBP GR) was made responsible for storage of all the Bt brinjal seeds in India. Indep endent testing labs are being currently being set up. Controversy There are many controversies about the development and release of genetically mo dified foods, ranging from human safety and environmental impacts to ethical con cerns such as corporate control of the food supply and intellectual property rig hts. The brinjal is an important food crop for India and the potential commercia lization of a genetically modified variety has drawn support and criticism. Alth ough it is a major food crop in India, brinjal production is relatively low with Fruit and Shoot Borer infestation a major constraint to yield. Proponents of th e technology believe the Bt brinjal will have positive effects for the Indian ec onomy and the health of the farmers. Field trials conducted on research-managed farms carried out by Mayhco and the Indian Council of Agricultural Research (ICA R) suggested a 42% pesticide reduction and a doubling of the yield was possible. [7] The economic gain for consumers, developers and farmers was estimated to pot entially be US$108 million per year with an additional $3â 4 million saved due to hea lth benefits associated with decreased pesticide use. French scientist, Gilles-Eric Seralini of the Committee for Independent Research and Information on Genetic Engineering (CRIIGEN) reviewed the safety informatio n. He raised concerns about some of the differences between feeding trials using the genetically modified and non-modified Brinjal and criticized some of the te sting protocols. The EC-II responded to the concerns raised by Seralini and othe r scientists in their report, although opponents asserted that these concerns we re not adequately addressed. Concerns have also been raised about a possible con flict of interest, with some of the scientists appointed to the GEAC being invol ved in developing their own GM products, that the decision by the EC-II was not unanimous, and about the reliability of safety data originating from Mahcyo run trials. The imposed moratorium has been criticized by some scientists as not bei ng based on any compelling scientific evidence and potentially setting Indian bi otechnology back decades. Others feel the critical issue is not the safety of th e GM technology, but its corporatization and there are claims that Indiaâ s crop prot ection industry was a major player in preventing the commercialization of the Bt brinjal.